Hosted on MSN1mon
Truist lifts Boston Scientific stock target to $120, maintains Buyas it also reported a beat in its Urology division and demonstrated profit and loss leverage. With revenue growth of 17.6% and a strong gross profit margin of 70%, Boston Scientific has maintained ...
In this photo illustration, the Boston Scientific company logo is seen ... [+] displayed on a smartphone screen. (Photo ...
Zacks Investment Research on MSN9d
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...
Boston Scientific Corp. engages in the development ... The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral ...
Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback